Lacrimal Devices Market Size Worth USD 238.24 Million By 2034
| Report Attributes | Key Statistics |
| Market Size in 2025 | USD 171.35 Million |
| Market Size in 2026 | USD 177.74 Million |
| Market Size by 2034 | USD 238.24 Million |
| Market Growth Rate (2025–2034) | CAGR of 3.73% |
| Leading Region in 2024 | North America |
| Second-Largest Region | Europe |
| Fastest-Growing Region | Asia-Pacific |
| Leading Product Segment (2024) | Stents |
| Fastest-Growing Product Segment | Incubation Sets |
| Key Growth Application | Dry Eye |
| Dominant End-use (2024) | Hospitals |
| Fastest-Growing End-use | Ophthalmic Clinics |
| Base Year | 2024 |
| Forecast Period | 2025–2034 |
| Historical Data | 2018–2023 |
| Segments Covered | Product, Application, End-use, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Key Drivers | Growing prevalence of dry eye disease, aging population, rising ophthalmic surgeries |
| Key Challenges | High device cost, limited reimbursement in developing nations |
| Key Companies | Include Carl Zeiss Meditec, Kaneka, Cook Medical, BVI Medical |
Immediate Delivery Available | Buy This Premium Research Report@
Lacrimal Devices Market Regional Insights
How Big is the U.S. Lacrimal Devices Market?
The U.S. lacrimal devices market size is valued at USD 43.18 million in 2025 and is anticipated to reach nearly USD 61.31 million by 2034, with a CAGR of 3.95% from 2025 to 2034.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@
How North America Dominated the Lacrimal Devices Market?
North America dominated the market in 2024, which was facilitated by the increased number of eye disorders like dry eye disease and nasolacrimal duct obstruction. The area is advantageous with a good healthcare system, early usage of advanced medical technologies, and the availability of advanced ophthalmic care.
The United States, specifically, dominates the market because it has the largest investment in healthcare, it has large medical equipment manufacturing companies, and it has a good research ecology. The current technological innovations, such as biodegradable stents
Why is Europe the Fastest-Growing in the Lacrimal Devices Market?
Europe experiences the fastest growth in the market during the forecast period, owing to the increasing knowledge about eye disorders and the growing avenues to advanced therapy. Germany is the most promising market in the European region because it has a large number of patients, an increasing healthcare spending, and a high rate of use of advanced medical technologies.
Moreover, firms within the region are developing well-organized direct channel alliances with ophthalmic clinics and hospitals to reach out to patients with greater effectiveness. Increasing geriatric populations in Europe, along with aggressive government programs in the area of eye health, are further propelling demand.
You can place an order or ask any questions, please feel free to contact at ... | +1 804 441 9344
Lacrimal Devices Market Segmentation Insights:
Product Insights
Why did the stents Cognitive Agents Segment Dominate the Market?
The stents segment dominated the market in 2024, because of its broad clinical usage and efficiency in preserving the tear drainage. Lacrimal stents are small tubes of metal, plastic, or fabric that are placed in the nasolacrimal system to maintain patency. They are usually applied to congenital obstructions in newborns, a decrease of complications post-surgery, infections, trauma, or malignancies, and other inflammatory diseases.
Stents help the flow of tears by ensuring the tear drainage pathway is not closed, so that the tears can flow into the nose. There are bi-canalicular and mono-canalicular types of stent. They are referred to as epipora, glaucoma, canalicular stenosis, obstruction of nasolacrimal ducts, and canalicular lacerations.
The incubation set segment is the fastest-growing in the market during the forecast period. Incubation sets are vital in surgery and diagnostics of the lacrimal system. They offer manipulated conditions and necessary assistance for handling and inserting the lacrimal apparatus, like stents. The adoption of incisionless sets is being triggered by increasing awareness about the use of minimally invasive eye procedures, technological changes in device design, and the need to have better results of the surgical procedures.
Application Insights
Which Application Segment Held the Largest Share of the Market?
The dry eye segment held the largest share in the market in 2024. Punctal plugs or other types of lacrimal devices are used to decrease excessive loss of tears down the nose and increase the duration that tears remain on the surface of the eye, thereby relieving general symptoms of burning, redness, itchiness, and dryness. Things like vision problems, corneal abrasions, ulcers, eye inflammation, and irritation are some of the complications of untreated dry eyes, which puts pressure on the need to treat it effectively.
Increased occurrences of dry eye disorders, coupled with the knowledge of sophisticated lacrimal interventions, are the two key elements that are spurring tremendous expansion in this segment.
End-Use Insights
How Hospital Segment Dominates the Market?
The hospital segment dominated the market in 2024, with its sophisticated infrastructure, equipment, and provision of advanced technology. With qualified ophthalmologists, nurses, and technicians, there is availability of a full-fledged diagnostic and treatment center for eye-related diseases in hospitals, where patients can receive adequate care and prompt treatment. The equipment to assist in the correct placement of the lacrimal devices, stents, and punctal plugs, which are essential in managing conditions like dry eye, nasolacrimal duct obstruction, and canalicular stenosis. Hospitals include better eye health outcomes, effective monitoring of patients, and affordable treatment opportunities.
The ophthalmic clinics segment is the fastest-growing in the market during the forecast period. Ophthalmic clinics are clinics that deal with eye diagnosis, treatment, and surgery all in one place. The market is experiencing growth due to the increase in awareness of eye health, the increasing rate of eye disorders, and the preference for special care of patients in clinics. Ophthalmic clinics offer easy access to highly developed care, individualized treatment plans, and effective follow-up services, which is why such clinics are appealing to patients and add significantly to the development of the lacrimal devices market.
✚ Related Topics You May Find Useful:
➡️ Stents Market➡️ Dry Eye Treatment Devices Market
➡️ Medical Devices Market
➡️ Ophthalmic Devices Market
➡️ ENT Devices Market
➡️ Sleep Apnea Devices Market
➡️ Ophthalmology Market
➡️ Medical Aesthetic Devices Market
Lacrimal Devices Market Top Companies
- Walsh Medical Devices Inc. JEDMED Braintree Scientific Kaneka Corporation Bess Medical Technology GmbH Rumex International Co Lacrimedics Inc. BVI Meddenium FCI Ophthalmic Gunther Weiss Scientific Glass
Recent Developments
In April 2025, Nordic Pharma was granted CE Mark approval on LACRIFILL to use in European markets. The milestone is beneficial to the company in its international growth as well as broader treatment access to patients with dry eye disease. Source:
In December 2023, Nordic Pharma (via its subsidiary Amring/Nordic Pharma, Inc.) purchased Visant Medical. This acquisition gave LACRIFILL canalicular gel to Nordic, which made it stronger in the market of treating eye dryness. Source:
Segments Covered in the Report
By Product
- Intubation Sets Tubes Stents Cannula & Spatula Dilator Punctal Plugs Others
By Application
- Dry Eye Glaucoma Epiphora Drainage Obstruction Lacrimal Gland Inflammation Others
By End-use
- Hospitals Ophthalmic Clinics Diagnostic Centers Others
By Region
- North America Asia Pacific Europe Latin America Middle East & Africa
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web:Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Market Stats Insight | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant Specialty Chemicals AnalyticsGet Recent News:
/newsFor the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment